Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

DNA Microarrays02:34

DNA Microarrays

Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The 'analysis of gene expression and biomarkers for point-of-care decision support in Sepsis' study; temporal clinical parameter analysis and validation of early diagnostic biomarker signatures for severe inflammation andsepsis-SIRS discrimination.

Frontiers in immunology·2024
Same author

Development of a Bioinformatics Framework for Identification and Validation of Genomic Biomarkers and Key Immunopathology Processes and Controllers in Infectious and Non-infectious Severe Inflammatory Response Syndrome.

Frontiers in immunology·2020
Same author

Distinctive Behaviors of Druggable Proteins in Cellular Networks.

PLoS computational biology·2015
Same author

canSAR: an updated cancer research and drug discovery knowledgebase.

Nucleic acids research·2015
Same author

Therapeutic opportunities within the DNA damage response.

Nature reviews. Cancer·2015
Same author

gEM/GANN: A multivariate computational strategy for auto-characterizing relationships between cellular and clinical phenotypes and predicting disease progression time using high-dimensional flow cytometry data.

Cytometry. Part A : the journal of the International Society for Analytical Cytology·2015
Same journal

Real-time EEG-based epileptic seizure prediction using artificial intelligence: A systematic review.

Artificial intelligence in medicine·2026
Same journal

R-peak detection and ECG data compression scheme based on empirical mode decomposition and wavelet transform.

Artificial intelligence in medicine·2026
Same journal

CastNet: A three-channel EEG-based deep learning model for cross-subject depression detection.

Artificial intelligence in medicine·2026
Same journal

State-of-the-art TinyML approaches for colorectal cancer detection: Current advances, challenges, and future directions.

Artificial intelligence in medicine·2026
Same journal

JRadiEvo: A Japanese radiology report generation model enhanced by evolutionary optimization of model merging.

Artificial intelligence in medicine·2026
Same journal

Causally-informed deep learning towards explainable and generalizable outcome prediction in critical care.

Artificial intelligence in medicine·2026
See all related articles

Related Experiment Video

Updated: May 30, 2026

DNA Microarrays: Sample Quality Control, Array Hybridization and Scanning
09:27

DNA Microarrays: Sample Quality Control, Array Hybridization and Scanning

Published on: March 15, 2011

Hybrid genetic algorithm-neural network: feature extraction for unpreprocessed microarray data.

Dong Ling Tong1, Amanda C Schierz

  • 1The John van Geest Cancer Research Centre, School of Science and Technology, Nottingham Trent University, UK. dong.tong@ntu.ac.uk

Artificial Intelligence in Medicine
|July 22, 2011
PubMed
Summary
This summary is machine-generated.

A new hybrid genetic algorithm-neural network (GANN) model effectively selects significant genes from raw microarray data for cancer research. This approach improves cancer classification accuracy and identifies novel biologically significant genes.

More Related Videos

Generating the Transcriptional Regulation View of Transcriptomic Features for Prediction Task and Dark Biomarker Detection on Small Datasets
03:37

Generating the Transcriptional Regulation View of Transcriptomic Features for Prediction Task and Dark Biomarker Detection on Small Datasets

Published on: March 1, 2024

Performing Custom MicroRNA Microarray Experiments
07:04

Performing Custom MicroRNA Microarray Experiments

Published on: October 28, 2011

Related Experiment Videos

Last Updated: May 30, 2026

DNA Microarrays: Sample Quality Control, Array Hybridization and Scanning
09:27

DNA Microarrays: Sample Quality Control, Array Hybridization and Scanning

Published on: March 15, 2011

Generating the Transcriptional Regulation View of Transcriptomic Features for Prediction Task and Dark Biomarker Detection on Small Datasets
03:37

Generating the Transcriptional Regulation View of Transcriptomic Features for Prediction Task and Dark Biomarker Detection on Small Datasets

Published on: March 1, 2024

Performing Custom MicroRNA Microarray Experiments
07:04

Performing Custom MicroRNA Microarray Experiments

Published on: October 28, 2011

Area of Science:

  • Bioinformatics
  • Computational Biology
  • Genomics

Background:

  • Microarray analysis is crucial for identifying cancer marker genes.
  • Existing machine learning methods prioritize classification over feature selection and require data preprocessing.
  • There is a need for methods that can perform feature selection on unpreprocessed microarray data.

Purpose of the Study:

  • To develop a hybrid genetic algorithm-neural network (GANN) model for enhanced feature selection in microarray analysis.
  • To enable the model to operate directly on unpreprocessed microarray data.
  • To improve the identification of biologically significant genes for cancer research.

Main Methods:

  • A hybrid genetic algorithm-neural network (GANN) model was developed.
  • The genetic algorithm's fitness was determined by an artificial neural network's classification accuracy.
  • The GANN model co-evolved the genetic algorithm's fitness function and neural network weights simultaneously.
  • The model was validated using two benchmark microarray datasets (acute leukemia and small round blue cell tumors).

Main Results:

  • The GANN model identified a significant set of genes, with approximately 50% overlap with previously identified genes, suggesting biological relevance.
  • Predictive models built using GANN-selected genes demonstrated higher accuracy on both datasets.
  • The GANN method successfully identified genes specific to single cancer types and those differentially expressed across multiple cancer types.

Conclusions:

  • The GANN model effectively extracts statistically and biologically significant genes from unpreprocessed microarray data.
  • Relying solely on classification accuracy for biological significance assessment can be misleading.
  • Further biological validation is recommended for newly identified genes to confirm their functionality.